Latest news

Thumbnail image for Norgine launches Shield’s Feraccru in the UK

Norgine launches Shield’s Feraccru in the UK

Norgine has launched Feraccru across the UK to treat patients with iron deficiency anaemia, having picked up rights to sell the drug from Shield Therapeutics earlier this year.

6th December 2018

Thumbnail image for New Vaccines Centre a ‘major commercial opportunity’

New Vaccines Centre a ‘major commercial opportunity’

Business Secretary Greg Clark MP has announced the UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC), said to represent a “major commercial opportunity”, and also a new front line in the nation’s defence against global pandemic threats.

5th December 2018

Thumbnail image for Johnson & Johnson pays $300m to develop cusatuzumab

Johnson & Johnson pays $300m to develop cusatuzumab

Johnson & Johnson's Janssen has entered into an agreement potentially worth up to $1.6 billion to develop and market Argenx' cusatuzumab for a number of cancers, including haematological malignancies.

5th December 2018

Thumbnail image for OPEN Health merges with Peloton Advantage

OPEN Health merges with Peloton Advantage

Health communications and market access group OPEN Health has merged with medical communications firm Peloton Advantage in a move designed to broaden the range of services available to clients.

5th December 2018

Thumbnail image for New cancer drugs taking longer to reach NHS patients

New cancer drugs taking longer to reach NHS patients

A new report by The Institute of Cancer Research (ICR) has found that NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use.

4th December 2018

Thumbnail image for Novartis’ SMA therapy gets US priority review

Novartis’ SMA therapy gets US priority review

US regulators have accepted for review Novartis’ Biologics License Application for Zolgensma, an investigational gene replacement therapy for the treatment of spinal muscular atrophy (SMA) Type 1.

4th December 2018

Previous  --   5 6 7 8 9 10 11 12 13 14   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download